Venus MedTech
Hangzhou, China· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
Overview
A medical device company developing transcatheter solutions for structural heart disease.
Cardiovascular
Technology Platform
A proprietary platform for designing and manufacturing nitinol-based transcatheter implantable devices and delivery systems for structural heart disease.
Opportunities
The underpenetrated and rapidly growing structural heart disease market in Asia presents a massive long-term growth opportunity.
Risk Factors
Product liability and complex, costly post-market clinical studies required for structural heart devices pose significant financial and reputational risks.
Competitive Landscape
Leads the domestic Chinese TAVR market but faces formidable global competitors when expanding internationally.